Irit Avivi Selected Research

Irit Avivi Research Topics

Disease

32	Multiple Myeloma 10/2023 - 01/2012
16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2023 - 05/2013
16	Neoplasms (Cancer) 08/2022 - 11/2010
15	Infections 08/2023 - 01/2004
13	Lymphoma (Lymphomas) 02/2024 - 03/2005
12	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 01/2012
9	COVID-19 08/2023 - 01/2021
6	Fever (Fevers) 11/2023 - 01/2012
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 01/2017
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2005
6	Hodgkin Disease (Hodgkin's Disease) 11/2019 - 02/2007
5	Residual Neoplasm 01/2023 - 11/2003
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 12/2009
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2019 - 04/2017
4	Leukemia 01/2019 - 04/2009
3	Disease Progression 02/2024 - 01/2016
3	Cytokine Release Syndrome 01/2024 - 01/2021
3	Immunoglobulin Light-chain Amyloidosis 12/2022 - 03/2018
3	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2016 - 01/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2015 - 11/2014
2	Febrile Neutropenia 11/2023 - 01/2018
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 04/2007
2	Body Weight (Weight, Body) 11/2023 - 12/2017
2	Plasmacytoma 12/2022 - 01/2020
2	Hemorrhage 01/2020 - 01/2020
2	Sepsis (Septicemia) 09/2019 - 09/2019
2	Myocarditis (Carditis) 09/2019 - 09/2019
2	Amyloidosis 03/2018 - 02/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2009 - 11/2003
1	Neutropenia 11/2023
1	beta-Thalassemia (Cooley's Anemia) 08/2023
1	Iron Overload 08/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Smoldering Multiple Myeloma 01/2023

Drug/Important Bio-Agent (IBA)

14	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2017
13	Rituximab (Mabthera)FDA Link 01/2021 - 01/2012
10	Bortezomib (Velcade)FDA Link 07/2020 - 01/2012
9	Lenalidomide (CC 5013)FDA Link 07/2023 - 08/2015
8	axicabtagene ciloleucelIBA 02/2024 - 12/2017
7	VaccinesIBA 05/2022 - 07/2013
6	B-Cell Maturation AntigenIBA 07/2023 - 12/2020
6	Proteasome InhibitorsIBA 01/2021 - 01/2017
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 08/2005
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 07/2023 - 12/2020
5	Messenger RNA (mRNA)IBA 11/2022 - 10/2021
5	BNT162 VaccineIBA 11/2022 - 10/2021
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2020 - 01/2017
4	AntigensIBA 11/2021 - 10/2014
4	ibrutinibIBA 01/2021 - 09/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2021
3	tocilizumab (atlizumab)FDA Link 01/2024 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2010
3	COVID-19 VaccinesIBA 10/2021 - 10/2021
3	ixazomibIBA 11/2020 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 08/2005
3	Vincristine (Oncovin)FDA LinkGeneric 11/2017 - 08/2005
3	Prednisone (Sone)FDA LinkGeneric 11/2017 - 08/2005
2	belantamab mafodotinIBA 10/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 08/2023 - 01/2021
2	AntibodiesIBA 08/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2021
2	fibrin fragment D (D-dimer)IBA 01/2023 - 11/2021
2	Fibrinogen (Factor I)FDA Link 01/2023 - 11/2021
2	tisagenlecleucelIBA 08/2022 - 01/2022
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2022 - 12/2016
2	daratumumabIBA 02/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 06/2020
2	NivolumabIBA 01/2021 - 02/2019
2	EnzymesIBA 01/2021 - 08/2015
2	venetoclaxIBA 10/2020 - 08/2019
2	pembrolizumabIBA 09/2019 - 09/2019
2	fludarabineIBA 12/2017 - 12/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2017 - 01/2014
2	Peptides (Polypeptides)IBA 10/2014 - 11/2010
2	Monoclonal AntibodiesIBA 09/2013 - 08/2012
2	Alemtuzumab (Campath)FDA Link 03/2004 - 12/2002
1	JNJ-64619178IBA 11/2023
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 11/2023
1	RNA Splicing FactorsIBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2023
1	IronIBA 08/2023
1	ElementsIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023

Therapy/Procedure

51	Therapeutics 02/2024 - 12/2002
16	Stem Cell Transplantation 07/2018 - 12/2002
14	Drug Therapy (Chemotherapy) 02/2023 - 03/2005
6	Cell Transplantation 02/2023 - 02/2017
3	Salvage Therapy 02/2023 - 01/2016
3	Immunotherapy 10/2021 - 07/2013
3	Transplantation 09/2019 - 12/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 12/2022
2	Hematopoietic Stem Cell Mobilization 07/2020 - 03/2017
2	Aftercare (After-Treatment) 03/2018 - 01/2012
2	Hematopoietic Stem Cell Transplantation 08/2016 - 11/2003
1	Blood Transfusion (Blood Transfusions) 08/2023